Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience

REIT With 89 Consecutive Dividend Payments Makes Best Dividend Stocks List

Dividend logo

Gilead Sciences, Inc. (GILD ) is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The company’s primary areas of focus are immunodeficiency virus (HIV), liver diseases, such as chronic hepatitis C virus (HCV) and chronic hepatitis B virus (HBV), oncology and inflammation, and serious cardiovascular and respiratory conditions. The company has two high-profile treatments: Harvoni and Sovaldi. These two drugs accounted for nearly 60% of the company’s revenue in both quarters of 2015.

Additionally, Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands approximately 75% of the U.S. treatment market and more than 50% worldwide.

Gilead Sciences recently started paying a quarterly dividend of $0.43 per share. Its first payout was on 6/29/2015. It’s going Ex-Dividend again on 9/14/2015. Its annual payout comes to $1.72, yielding 1.50% on its current price of $114.

To read the Full Story, Go Premium or Log In

Popular Articles

Best Online Brokers

At Dividend.com a large portion of our readership is of a discerning, self-directed nature. As...

Premium Shutterstock 379786975

Bond Market Woes Could Spell Stock Opportunities

It’s been axiomatic – since basically forever – that as interest rates fall, the stock market...

Premium Shutterstock 352414943

The Market Glance for October 24: 3M Goes for Another Big Beat

For investors, last week started off badly, but ended up realizing gains by the time the last...